newsfilter
← Latest News
FDA Approved Drugs·

Approval of Rezlidhia, Nda #215814 (Type 1 - New Molecular Entity)

Approval Date: 12/01/2022; Drug Name: Rezlidhia, Nda #215814; Active Ingredients: OLUTASIDENIB; Company: Forma Therapeutics, Inc; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 215814

Company
FORMA THERAPEUTICS, INC
Keywords
FORMA THERAPEUTICS, INC